The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

On-Demand Educational Webinars
Supply Chain's Role in Non-Labor Expense Management (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Supply chain leaders share their processes and experiences in managing non-labor and non-personnel expenses.
On-Demand Educational Webinars
The Provider Perspective on Building Supply Chain Resiliency (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Provider panelists discuss their post-pandemic approach to their business continuity programs, working with non-traditional buyers, diversifying…
Podcasts
Sourcing Strategies During and After COVID-19
Michael Brown, Director of Supply Chain Management and Eric Swaim, Manager of Strategic Sourcing and Vendor Management at Texas Children’s Hospital…
On-Demand Educational Webinars
The Manufacturer and Distributor Perspective on Building Supply Chain Resiliency (Re-engineering the Health Care Supply Chain: CQO Thought Leader Discussion Series)
Listen as distributor and manufacturer panelists discuss their changing strategies relating to COVID-19 lessons, domestic verses international…
Webcast
NextGen Leadership Capabilities
Dr. Randy Bradley discusses the attributes leaders must have in order to be effective when managing a multi-generational workforce.
Webcast
UDI Value in Recall Management
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r